Literature DB >> 18606650

Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis.

Jan D Lünemann1, Oliver Frey, Thorsten Eidner, Michael Baier, Susanne Roberts, Junji Sashihara, Rudolf Volkmer, Jeffrey I Cohen, Gert Hein, Thomas Kamradt, Christian Münz.   

Abstract

EBV is a candidate trigger of rheumatoid arthritis (RA). We determined both EBV-specific T cell and B cell responses and cell-associated EBV DNA copies in patients with RA and demographically matched healthy virus carriers. Patients with RA showed increased and broadened IgG responses to lytic and latent EBV-encoded Ags and 7-fold higher levels of EBV copy numbers in circulating blood cells. Additionally, patients with RA exhibited substantial expansions of CD8(+) T cells specific for pooled EBV Ags expressed during both B cell transformation and productive viral replication and the frequency of CD8(+) T cells specific for these Ags correlated with cellular EBV copy numbers. In contrast, CD4(+) T cell responses to EBV and T cell responses to human CMV Ags were unchanged, altogether arguing against a defective control of latent EBV infection in RA. Our data show that the regulation of EBV infection is perturbed in RA and suggest that increased EBV-specific effector T cell and Ab responses are driven by an elevated EBV load in RA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606650      PMCID: PMC2570434          DOI: 10.4049/jimmunol.181.2.991

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes.

Authors:  E Scotet; M A Peyrat; X Saulquin; C Retiere; C Couedel; F Davodeau; N Dulphy; A Toubert; J D Bignon; A Lim; H Vie; M M Hallet; R Liblau; M Weber; J M Berthelot; E Houssaint; M Bonneville
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

3.  Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.

Authors:  J L Grogan; A Kramer; A Nogai; L Dong; M Ohde; J Schneider-Mergener; T Kamradt
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

Review 4.  Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection.

Authors:  Thomas Kamradt; Rolf Göggel; Klaus J Erb
Journal:  Trends Immunol       Date:  2005-05       Impact factor: 16.687

5.  Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis.

Authors:  A La Cava; J L Nelson; W E Ollier; A MacGregor; E C Keystone; J C Thorne; J F Scavulli; C C Berry; D A Carson; S Albani
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

6.  EBV and systemic lupus erythematosus: a new perspective.

Authors:  Andrew J Gross; Donna Hochberg; William M Rand; David A Thorley-Lawson
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.

Authors:  Tatjana Klatt; Qin Ouyang; Thomas Flad; Ina Koetter; Hans-Jörg Bühring; Hubert Kalbacher; Graham Pawelec; Claudia A Müller
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

8.  A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity.

Authors:  G Stucki; M H Liang; S Stucki; P Brühlmann; B A Michel
Journal:  Arthritis Rheum       Date:  1995-06

9.  Impaired early B cell tolerance in patients with rheumatoid arthritis.

Authors:  Jonathan Samuels; Yen-Shing Ng; Claire Coupillaud; Daniel Paget; Eric Meffre
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

10.  Defective B cell tolerance checkpoints in systemic lupus erythematosus.

Authors:  Sergey Yurasov; Hedda Wardemann; Johanna Hammersen; Makoto Tsuiji; Eric Meffre; Virginia Pascual; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307

View more
  23 in total

1.  In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin.

Authors:  M Cornillet; E Verrouil; A Cantagrel; G Serre; L Nogueira
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.

Authors:  Jan D Lünemann; Mar Tintoré; Brady Messmer; Till Strowig; Alex Rovira; Héctor Perkal; Estrella Caballero; Christian Münz; Xavier Montalban; Manuel Comabella
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

3.  Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.

Authors:  Seiji Kondo; Kazuki Tanimoto; Kozue Yamada; Goichi Yoshimoto; Eiichi Suematsu; Tomoaki Fujisaki; Yumi Oshiro; Kazuo Tamura; Morishige Takeshita; Seiichi Okamura
Journal:  Virchows Arch       Date:  2013-03-14       Impact factor: 4.064

4.  ERAP1 functions override the intrinsic selection of specific antigens as immunodominant peptides, thereby altering the potency of antigen-specific cytolytic and effector memory T-cell responses.

Authors:  David P W Rastall; Yasser A Aldhamen; Sergey S Seregin; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2014-08-02       Impact factor: 4.823

Review 5.  Antiviral immune responses: triggers of or triggered by autoimmunity?

Authors:  Christian Münz; Jan D Lünemann; Meghann Teague Getts; Stephen D Miller
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

6.  A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.

Authors:  John M Davis; Keith L Knutson; John A Skinner; Michael A Strausbauch; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Res Ther       Date:  2012-01-31       Impact factor: 5.156

7.  Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice.

Authors:  Lisa Bruns; Oliver Frey; Lars Morawietz; Christiane Landgraf; Rudolf Volkmer; Thomas Kamradt
Journal:  Arthritis Res Ther       Date:  2009-07-29       Impact factor: 5.156

8.  Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies.

Authors:  Corinne Miceli-Richard; Nicolas Gestermann; Corinne Amiel; Jérémie Sellam; Marc Ittah; Stephan Pavy; Alejandra Urrutia; Isabelle Girauld; Guislaine Carcelain; Alain Venet; Xavier Mariette
Journal:  Arthritis Res Ther       Date:  2009-05-26       Impact factor: 5.156

Review 9.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

10.  Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes.

Authors:  Jack Peter; Oliver Frey; Andreas Stallmach; Tony Bruns
Journal:  BMC Gastroenterol       Date:  2013-02-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.